Bu J - Search Results

1

KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes.

Qiao X, Zhang Y, Zhang Z, Niu N, Li H, Sun L, Ma Q, Bu J, Liu J, Chen G, Xue J, Yang Y, Liu C. Qiao X, et al. Among authors: bu j. Asian J Pharm Sci. 2023 May;18(3):100814. doi: 10.1016/j.ajps.2023.100814. Epub 2023 May 12. Asian J Pharm Sci. 2023. PMID: 37274925 Free PMC article.

2

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients.

Zhu X, Zhang Y, Bai Y, Gu X, Chen G, Sun L, Wang Y, Qiao X, Ma Q, Zhu T, Bu J, Xue J, Liu C. Zhu X, et al. Among authors: bu j. Int J Med Sci. 2020 Sep 30;17(17):2773-2789. doi: 10.7150/ijms.43161. eCollection 2020. Int J Med Sci. 2020. PMID: 33162805 Free PMC article.

3

CEMIP as a potential biomarker and therapeutic target for breast cancer patients.

Xue J, Zhu X, Qiao X, Wang Y, Bu J, Zhang X, Ma Q, Liang L, Sun L, Liu C. Xue J, et al. Among authors: bu j. Int J Med Sci. 2022 Feb 7;19(3):434-445. doi: 10.7150/ijms.58067. eCollection 2022. Int J Med Sci. 2022. PMID: 35370456 Free PMC article.

4

The altering in sensory sensitivity: a current issue of female breast surgery.

Zhu T, Jiang Y, Liu T, Xue J, Niu N, Bu J, Liu M, Liu C, Zhu X, Gu X. Zhu T, et al. Among authors: bu j. Int J Med Sci. 2022 May 16;19(5):901-908. doi: 10.7150/ijms.71913. eCollection 2022. Int J Med Sci. 2022. PMID: 35693749 Free PMC article. Review.

5

A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44⁺CD24^- enriched breast cancer stem-like cells.

Liu C, Zhang Y, Gao J, Zhang Q, Sun L, Ma Q, Qiao X, Li X, Liu J, Bu J, Zhang Z, Han L, Zhao D, Yang Y. Liu C, et al. Among authors: bu j. Drug Resist Updat. 2023 Jan;66:100903. doi: 10.1016/j.drup.2022.100903. Epub 2022 Nov 20. Drug Resist Updat. 2023. PMID: 36463808 Free article.

6

Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.

Shen Y, Xue J, Yu J, Jiang Y, Bu J, Zhu T, Gu X, Zhu X. Shen Y, et al. Among authors: bu j. World J Surg Oncol. 2022 Dec 15;20(1):398. doi: 10.1186/s12957-022-02871-0. World J Surg Oncol. 2022. PMID: 36517818 Free PMC article.

7

Targeting SOST using a small-molecule compound retards breast cancer bone metastasis.

Sun L, Zhang Y, Chen G, Ji Y, Ma Q, Qiao X, Wu S, Zhou L, Bu J, Zhu X, Zhang X, Jiang X, Liu C, Li X, Liu Y, Yang Y, Liu C. Sun L, et al. Among authors: bu j. Mol Cancer. 2022 Dec 29;21(1):228. doi: 10.1186/s12943-022-01697-4. Mol Cancer. 2022. PMID: 36581888 Free PMC article.

8

Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2⁺HR⁺ breast cancer.

Bu J, Zhang Y, Niu N, Bi K, Sun L, Qiao X, Wang Y, Zhang Y, Jiang X, Wang D, Ma Q, Li H, Liu C. Bu J, et al. Elife. 2023 Jan 5;12:e85246. doi: 10.7554/eLife.85246. Elife. 2023. PMID: 36602226 Free PMC article.

9

KK-LC-1 as a therapeutic target to eliminate ALDH⁺ stem cells in triple negative breast cancer.

Bu J, Zhang Y, Wu S, Li H, Sun L, Liu Y, Zhu X, Qiao X, Ma Q, Liu C, Niu N, Xue J, Chen G, Yang Y, Liu C. Bu J, et al. Nat Commun. 2023 May 5;14(1):2602. doi: 10.1038/s41467-023-38097-1. Nat Commun. 2023. PMID: 37147285 Free PMC article.

10

Advances in immunotherapy for triple-negative breast cancer.

Liu Y, Hu Y, Xue J, Li J, Yi J, Bu J, Zhang Z, Qiu P, Gu X. Liu Y, et al. Among authors: bu j. Mol Cancer. 2023 Sep 2;22(1):145. doi: 10.1186/s12943-023-01850-7. Mol Cancer. 2023. PMID: 37660039 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

788 results

Search Page

Filters